Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-014185
Filing Date
2025-05-22
Accepted
2025-05-22 17:00:11
Documents
1
Period of Report
2025-05-20

Document Format Files

Seq Description Document Type Size
1 form4-05222025_050503.html 4  
1 form4-05222025_050503.xml 4 7195
  Complete submission text file 0001415889-25-014185.txt   8736
Mailing Address 2000 GALLOPING HILL ROAD C/O SCHERING PLOUGH CORP KENILWORTH NJ 07033
Business Address
SAUNDERS BRENT L (Reporting) CIK: 0001268854 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 25978043

Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Issuer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)